Documents on Display
Filed with HKEX · Stock code 2496 · · English
Summary by 6ix AI
This filing is a notification letter from Wuhan YZY Biopharma Co., Ltd. regarding documents available for display.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Wuhan YZY Biopharma Co., Ltd. on 6ix
Earlier from Wuhan YZY Biopharma
- Form of proxy for the extraordinary general meeting to be held on Tuesday, 17 November 2026
- Notice of extraordinary general meeting
- (1) Connected transaction in respect of the proposed issue of new domestic shares under Specific mandate; (2) application for Whitewash Waiver; (3) proposed amendments to the articles of association; and (4) notice of EGM
- Closure of register of members for extraordinary general meeting
- Voluntary announcement the first patient dosed in phase i clinical trial of Y225 for treatment of hemophilia a
Later from Wuhan YZY Biopharma
- Announcement despatch of circular in relation to (1) connected transaction in respect of the proposed issue of new domestic shares under Specific mandate; (2) application for Whitewash Waiver; and (3) proposed amendments to the articles of association
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow Wuhan YZY Biopharma into a list and get an email when it puts out news.
Follow Wuhan YZY Biopharma